BMS to join ranks of AIDS drug companies to offer price concessions

Bristol-Myers Squibb (BMS) will soon announce an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide. The agreement, with the ADAP Crisis Task Force (ACTF) of the National Alliance of State & Territorial Directors (NASTAD), is expected to be announced any day. BMS has been the target of a sustained advocacy campaign led by AHF over its pricing of its key Reyataz.


Read more

Related posts

Leave a Reply